BioSpace News Archive

Business

Mirion Technologies Announces Date for Quarterly Earnings Release Conference Call

Mirion Technologies, Inc. (NYSE: MIR), announced today that it will release financial results for Mirion Technologies (TopCo), Ltd for the fiscal quarter ended September 30, 2021, on Friday, November 12, 2021 before the market opens.

November 5, 2021
·
1 min read
Biotech Beach

Bluestar Genomics Presents New Data Showing its Liquid Biopsy Test Detects Pancreatic Cancer Signal

Bluestar Genomics today announced the presentation of new analytical performance data on its proprietary non-invasive pancreatic cancer test at the American Pancreatic Association (APA) annual meeting.

November 5, 2021
·
5 min read
Genetown

PerkinElmer to Present at 2021 Stifel Healthcare Conference

PerkinElmer, Inc. today announced that the Company will present at the virtual 2021 Stifel Healthcare Conference on Tuesday, November 16, 2021 at 8:40 a.m. ET.

November 5, 2021
·
1 min read
Biotech Bay

Veracyte Announces Immunoscore Colon Cancer Test Included in ESMO Clinical Practice Guidelines Adapted for Pan-Asia

Veracyte, Inc . (Nasdaq: VCYT) today announced that its Immunoscore Colon Cancer test has been included in the Pan-Asian adapted ESMO 1 Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with localized colon cancer.

November 5, 2021
·
6 min read
Business

Xtant Medical to Issue Third Quarter 2021 Financial Results on November 12, 2021

Xtant Medical Holdings, Inc. today announced that it will release its financial results for the third quarter ended September 30, 2021, before the open of the financial markets on Friday, November 12, 2021.

November 5, 2021
·
1 min read
Drug Development

Longeveron Selects Clinical Research Organization for Phase 2 Alzheimer’s Disease Trial

Longeveron Inc. today announced the selection of Biorasi LLC (“Biorasi”) as its clinical research organization (CRO) to help conduct its Phase 2 clinical trial evaluating Lomecel-B infusion in Alzheimer’s Disease (AD) subjects.

November 5, 2021
·
4 min read
Reven Holdings Announces the Publication of a Peer-reviewed Article in the Prestigious Medical Journal Frontiers in Oncology

Reven Holdings, Inc. today announced the publication of a peer-reviewed article in the prestigious medical journal Frontiers in Oncology.

November 5, 2021
·
7 min read
BioForest

Omeros’ Narsoplimab Stabilized Kidney Function and Reduced Urinary Complement Proteins in a Patient with IgA Vasculitis

Omeros Corporation (Nasdaq: OMER) today announced that the first report on urinary complement levels in kidney disease was presented yesterday at the Annual Meeting of the American Society of Nephrology.

November 5, 2021
·
7 min read
Pharm Country

Delcath Systems to Hold Investor Update on Focus Trial Data and Future Development Plans on December 2, 2021

Delcath Systems, Inc. announced today it will host a comprehensive Investor Update event on Thursday, December 2 nd , from 10:00am ET – 1:00pm ET.

November 5, 2021
·
1 min read
Genetown

Clinical Cancer Research Publishes a Systematic Review of Regulatory Real-World Evidence in Successful Oncology Product Approvals

Analysis Group today announced the publication of research examining the US Food and Drug Administration’s (FDA’s) commentary on the use of real-world evidence (RWE) in successful oncology product approvals between 2015 and 2020.

November 5, 2021
·
4 min read